Cipla hones in on Melbourne with investment
March 14, 2013
MUMBAI-based pharmaceutical giant Cipla has opened its Australian headquarters in Melbourne. Cipla is the world's largest manufacturer of antiretroviral drugs for patients with HIV/AIDS and has a turnover of US$1.4 billion per annum and more than 20,000 employees worldwide. One of the first investments by the company in a regional office outside India, the local office was officially opened by Dr Amanda Caples, Executive Director, Science & Technology Programs on behalf of the Victorian Govt. “Through our local staff Cipla will provide superior service to existing customers, build its customer base and provide expert advice to our R&D department on requirements of the Australian medicines market for future product opportunities,” said Oskar Hakansson, Cipla Head - Australia & New Zealand. Hakansson is pictured right with Dr Caples opening the new Melbourne headquarters.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 13